-
-
-
-
-
-
-
HSBC downgrades Illumina on China risks, funding concerns
-
-
-
-
-
-
-
Roche Completes Acquisition of Telavant from Roivant, Including Rights to Novel TL1A Directed Antibody (RVT-3101) for the Treatment of Inflammatory Bowel Disease
-
-
-
-
-
-
-
Rogers Corporation Reports First Quarter 2023 Results
-
-
-
-
-
-
-
Rogers Announces Agreement with Starboard Value
-
-
-
-
-
-
-
Rogers Announces Leadership Transition
-
-
-
-
-
-
-
Rogers Issues Statement Regarding DuPont’s Notice of Termination of Merger Agreement
-
-
-
-
-
-
-
Spark Therapeutics Announces Departure of CEO and Founder Jeff Marrazzo; COO Ron Philip Named as Successor
-
1,157,905 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

